SCHEMBL8485993

SCHEMBL8485993

Cc1ccc([C@H]2Sc3cc(C)ccc3NC(=O)[C@H]2O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.58
TDP1 Q9NUW8 3/20 0.58
ALOX15 P16050 3/20 0.58
HSD17B10 Q99714 3/20 0.58
USP2 O75604 2/20 0.58
POLB P06746 2/20 0.58
ESR1 P03372 1/20 0.58
THRB P10828 1/20 0.58
HPGD P15428 1/20 0.58
PTPN7 P35236 1/20 0.58
RECQL P46063 1/20 0.58
ESR2 Q92731 1/20 0.58
CTDSP1 Q9GZU7 1/20 0.58
EPHX2 P34913 1/20 0.43
MAPT P10636 6/20 0.42
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
HTT P42858 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9189552 1.00 KDM4E (0.58) KDM4ETDP1ALOX15HSD17B10USP2
SCHEMBL9189547 1.00 KDM4E (0.58) KDM4ETDP1ALOX15HSD17B10USP2
SCHEMBL10599133 0.90 HSD17B10 (0.51) KDM4ETDP1ALOX15HSD17B10USP2
SCHEMBL10599130 0.90 HSD17B10 (0.51) KDM4ETDP1ALOX15HSD17B10USP2
SCHEMBL10599118 0.90 HSD17B10 (0.51) KDM4ETDP1ALOX15HSD17B10USP2
SCHEMBL11018324 0.90 POLB (0.53) KDM4ETDP1ALOX15HSD17B10USP2
SCHEMBL11018327 0.90 POLB (0.53) KDM4ETDP1ALOX15HSD17B10USP2
SCHEMBL10898993 0.90 POLB (0.53) KDM4ETDP1ALOX15HSD17B10USP2
SCHEMBL11021133 0.89 POLB (0.58) KDM4ETDP1ALOX15HSD17B10USP2
SCHEMBL11021134 0.89 POLB (0.58) KDM4ETDP1ALOX15HSD17B10USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5883264-A SUBJECTING RACEMIC TRANS-3-PHENYLGLYCIDAMIDE COMPOUND TO OPTICAL RESOLUTION USING A MICROORGANISM HAVING ABILITY OF PREFERENTIALLY HYDROLYZING ONE OF (2S,3R) ISOMER OR (2R,3S) ISOMER THEREOF TANABE SEIYAKU CO., LTD. (JP) 1999-03-16 US disclosed
US-5847122-A Process for preparing 1,5-benzothiazepine derivative TANABE SEIYAKU CO., LTD. (JP) 1998-12-08 US disclosed
EP-0795609-A2 Process for preparing optically active trans-3-phenylglycidamide compounds TANABE SEIYAKU CO., LTD. (JP) 1997-09-17 EP disclosed
EP-0792876-A2 Process for preparing 1,5-benzothiazepine derivative TANABE SEIYAKU CO., LTD. (JP) 1997-09-03 EP disclosed
EP-0395302-B1 Process for preparing 1,5-benzothiazepine derivatives TANABE SEIYAKU CO (JP) 1995-01-04 EP disclosed
EP-0612737-A1 Process for preparing 1,5-benzothiazepine derivatives TANABE SEIYAKU CO., LTD. (JP) 1994-08-31 EP disclosed
US-5310904-A Intermediate TANABE SEIYAKU CO., LTD. (JP) 1994-05-10 US disclosed
EP-0551076-A1 Process for preparing optically active benzothiazepine compounds by asymmetric reduction TANABE SEIYAKU CO., LTD. (JP) 1993-07-14 EP disclosed
US-5128469-A Catalytic ring closure with organic sulfonic acid; amidation TANABE SEIYAKU CO., LTD. (JP) 1992-07-07 US disclosed
US-5055575-A Process for preparing 1,5-benzothiazepine derivatives TANABE SEIYAKU CO., LTD. (JP) 1991-10-08 US disclosed
EP-0395302-A1 Process for preparing 1,5-benzothiazepine derivatives TANABE SEIYAKU CO., LTD. (JP) 1990-10-31 EP disclosed
EP-0158340-B1 NOVEL 1,5-BENZOTHIAZEPINE DERIVATIVE, PROCESSES FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS Tanabe Seiyaku Co., Ltd. (JP) 1989-01-18 EP disclosed
US-4594342-A Anticoagulants TANABE SEIYAKU CO., LTD. (JP) 1986-06-10 US disclosed
EP-0158340-A2 Novel 1,5-benzothiazepine derivative, processes for preparing the same and pharmaceutical compositions Tanabe Seiyaku Co., Ltd. (JP) 1985-10-16 EP disclosed